Pharmaids Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Pharmaids Pharma from all sources in a single place.

07 Apr 2026

31.41

2.08%

Company Update

Pharmaids Pharmaceuticals Ltd - 524572 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

pdf

Pharmaids Pharmaceuticals Ltd.

27 Mar 2026

31.41

2.08%

Company Update

Pharmaids Pharmaceuticals Ltd - 524572 - Intimation Under Regulation 30 Of SEBI LODR

BSE India

Sale of entire shareholding held by Adita Bio Sys Private Limited (material subsidiary of the Company) in Siri Labvivo Diet Private Limited, a step-down subsidiary, resulting in cessation of its subsidiary status w.e.f March 27, 2026.

pdf

Pharmaids Pharmaceuticals Ltd.

25 Mar 2026

31.41

2.08%

SAST

Pharmaids Pharmaceuticals Ltd - 524572 - Closure of Trading Window

BSE India

Intimation of Trading Window Closure pursuant to declaration of Audited Financial Results for the quarter and Year ended March 31, 2026.

pdf

Pharmaids Pharmaceuticals Ltd.

24 Feb 2026

31.41

2.08%

Company Update

Pharmaids Pharmaceuticals Ltd - 524572 - Intimation Of Receipt Of Accreditation By The American Association For …

BSE India

Intimation under Regulation 30 of LODR.

pdf

Pharmaids Pharmaceuticals Ltd.

15 Feb 2026

31.41

2.08%

Company Update

Pharmaids Pharmaceuticals Ltd - 524572 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Corrigendum to the newspaper publication dated February 14, 2026, regarding unaudited financial results (Consolidated and Standalone) for the quarter and nine months ended December 31, 2025.

pdf

Pharmaids Pharmaceuticals Ltd.

14 Feb 2026

31.41

2.08%

Company Update

Pharmaids Pharmaceuticals Ltd - 524572 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication of unaudited financial results (Consolidated and Standalone) for the quarter and nine months ended December 31, 2025.

pdf

Pharmaids Pharmaceuticals Ltd.

12 Feb 2026

31.41

2.08%

Company Update

Pharmaids Pharmaceuticals Ltd - 524572 - Report Of Auditors On Financial Results For The Quarter And …

BSE India

Report of Auditors on Financial Results for the quarter and nine months ended December 31, 2025 with UDIN

pdf

Pharmaids Pharmaceuticals Ltd.

12 Feb 2026

31.41

2.08%

Result

Pharmaids Pharmaceuticals Ltd - 524572 - Unaudited Financial Results For The Quarter And Nine Months Ended …

BSE India

Unaudited financial results for the quarter and nine months ended December 31, 2025

pdf

Pharmaids Pharmaceuticals Ltd.

12 Feb 2026

31.41

2.08%

Board Meeting

Pharmaids Pharmaceuticals Ltd - 524572 - Board Meeting Outcome for Outcome Of The Board Meeting.

BSE India

Outcome of the Board Meeting held on Thursday, February 12, 2026, i.e, today, to consider and approve the un-audited financial results for the quarter and nine months ended December 31, 2025.

pdf

Pharmaids Pharmaceuticals Ltd.

09 Feb 2026

31.41

2.08%

Board Meeting

Pharmaids Pharmaceuticals Ltd - 524572 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial …

BSE India

Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025.

pdf

Is Pharmaids Pharmaceuticals Ltd. worth buying?

13 Votes:

Buy 53.85%

Sell 30.77%

Hold 15.38%

57.24% Fall from 52W High

High volume today

Pharmaids Pharma News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Pharmaids Pharma from all sources in a single place.